Skip to main content
OpenTrials
Completed

NCT Number: NCT07785518

Prevalenza Della Insulino Resistenza e Correlate Malattie Cardiovascolari Nella città di Napoli

This is an observational retrospective study to verify the prevalence of insulin resistance (IR) in the municipality of Naples and ita association with cardiovascular diseases.

Primary outcome measure 1: The prevalence of IR. Primary outcome measure 2: The prevalence of cardiovascular diseases in subjects with IRnand in subjects without IR.

The data for analysis will be derived from the database of COMEGEN, a cooperative of general practitioners (ASL Napoli 1 Centro)who follow about 200,000 individuals of the ten districts of the municipality of Naples. As surrogate index of IR will be used the TyG with the cutoff ≥8.5. Aldo the prevalence of cardiovascular diseases in the two groups will be derivedby the registered cardiovascular diseases in the database.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Insulin Resistance Syndrome Cardio Vascular Disease Cardiovascular Diseases Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Metabolic Diseases Metabolic Syndrome Nutritional and Metabolic Diseases Prevalence

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Comune di Napoli

Naples, 80100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all the subjects who have a registered value of glucose and triglycerides in the same day within the last 6 months

Exclusion criteria

  • diagnosis of overt diabetes

Treatment and study plan

No Intervention: Observational Cohort

Other

There is no intervention

Primary outcomes

  1. Prevalence of insulin resistance

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

Comune di Napoli

Other

Registry information

Official study title

Studio Epidemilogico Per Valutare la Prevalenza Della Insulino Resistenza Nell'Area Metropolitana di Napoli e Della Sua Relazione Con Malattie Cardiovascolari

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 25, 2026
Registry last updated
Aug 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.